Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
609.00    -7.00 (-1.14%)
Bid:
609.00
Ask:
611.00
Spread: 2.00 (0.328%)
Market Cap: £530.59m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

AGM and Interim Management Statement

9 Feb 2010 07:00

RNS Number : 8437G
Victrex PLC
09 February 2010
 



 

 9 February 2010

Victrex plc

 

AGM and Interim Management Statement

 

At the Annual General Meeting of Victrex plc to be held today, Chairman Anita Frew will make the following statement which comprises Victrex's Interim Management Statement covering the period from 1 October 2009 to date:

 

"We are pleased to report that Group sales volume for the four months to the end of January amounted to approximately 714 tonnes consolidating the positive trend in volumes in our Victrex Polymer Solutions ('VPS') business that we indicated in our preliminary results announcement in December. As expected, December sales volumes were lower than the average for the first two months of the financial year, reflecting the normal seasonal trend. However, January sales volumes rebounded and showed further growth over October and November as customers recommenced activity in the New Year. While it remains too early to predict the outcome for the year as a whole, the underlying trends being experienced across VPS are encouraging.

 

Invibio®, our biomaterials business, continues to make good progress following reduced revenue in the second half of last year caused principally by inventory rationalisation. Revenues for the four months to the end of January were at similar levels to the average run rate we achieved in 2009 (annual sales revenue of £34.2m). We remain confident that Invibio revenue for 2010 will show continued growth.

 

The Group remains in a strong financial position with a healthy balance sheet and good cash generation and there have been no significant changes in the financial position of the Company since 30 September 2009."

 

The Company's trading update for the six months to 31 March 2010 will be issued on Thursday 8 April 2010.

 

 

Enquiries

 

Victrex plc

Anita Frew, Chairman 0207 357 9477 (9 February 2010)

David Hummel, Chief Executive 01253 897700 (thereafter)

Mike Peacock, Finance Director

 

Hogarth Partnership Limited

Nick Denton / Barnaby Fry 0207 357 9477

 

 

Victrex plc is an innovative world leader in high performance materials through the manufacture of VICTREX® PEEK™ polymer, a high performance, easy to process thermoplastic.

 

With over 30 years of experience, Victrex is a global manufacturer of innovative, high performance thermoplastic polymers. We work with customers and end users to deliver technology driven solutions to the challenges and opportunities they face. Our Victrex Polymer Solutions division ('VPS') focuses on our transport, industrial and electronics markets and our Invibio Biomaterial Solutions division ('Invibio') focuses on providing specialist solutions for medical device manufacturers.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMZMGGZVRZGGZM
Date   Source Headline
4th Jan 20121:38 pmRNSAnnual Information Update
4th Jan 201211:35 amRNSAnnual Financial Report
3rd Jan 201211:23 amRNSHolding(s) in Company
30th Dec 201112:00 pmRNSTotal Voting Rights
19th Dec 201112:00 pmRNSDirector/PDMR Shareholding
13th Dec 20113:43 pmRNSDirector/PDMR Shareholding
6th Dec 20117:00 amRNSFinal Results
1st Dec 201111:24 amRNSBlocklisting Interim Review
30th Nov 201111:48 amRNSTotal Voting Rights
17th Nov 201111:43 amRNSDirector/PDMR Shareholding
2nd Nov 20114:22 pmRNSHolding(s) in Company
31st Oct 20111:52 pmRNSTotal Voting Rights
19th Oct 20111:45 pmRNSDirector/PDMR Shareholding
6th Oct 20113:27 pmRNSHolding(s) in Company
6th Oct 20117:02 amRNSDirectorate Change
6th Oct 20117:00 amRNSYear End Trading Update
30th Sep 20112:14 pmRNSTotal Voting Rights
19th Sep 20114:22 pmRNSDirector/PDMR Shareholding
6th Sep 20112:52 pmRNSHolding(s) in Company
31st Aug 20113:38 pmRNSTotal Voting Rights
17th Aug 20113:26 pmRNSDirector/PDMR Shareholding
10th Aug 201110:48 amRNSHolding(s) in Company
4th Aug 20117:00 amRNSInterim Management Statement
29th Jul 20113:52 pmRNSTotal Voting Rights
29th Jul 20112:05 pmRNSHolding(s) in Company
19th Jul 20113:59 pmRNSHolding(s) in Company
19th Jul 20111:40 pmRNSDirector/PDMR Shareholding
4th Jul 20114:09 pmRNSHolding(s) in Company
1st Jul 20111:23 pmRNSTotal Voting Rights Replacement
30th Jun 20113:38 pmRNSDirector/PDMR Shareholding
27th Jun 20111:47 pmRNSHolding(s) in Company
17th Jun 20112:21 pmRNSDirector/PDMR Shareholding
8th Jun 20113:55 pmRNSDirector/PDMR Shareholding
1st Jun 201111:07 amRNSBlocklisting Interim Review
1st Jun 201111:01 amRNSTotal Voting Rights
24th May 20117:00 amRNSHalf Yearly Report
18th May 20112:20 pmRNSDirector/PDMR Shareholding
6th May 20112:53 pmRNSHolding(s) in Company
5th May 20114:22 pmRNSHolding(s) in Company
4th May 20113:00 pmRNSTotal Voting Rights
4th May 20112:51 pmRNSHolding(s) in Company
19th Apr 20112:44 pmRNSDirector/PDMR Shareholding
7th Apr 20117:00 amRNSTrading Update
1st Apr 201111:00 amRNSTotal Voting Rights
25th Mar 20111:59 pmRNSDirector Declaration
17th Mar 20112:44 pmRNSDirector/PDMR Shareholding
14th Mar 201112:30 pmRNSHolding(s) in Company
2nd Mar 201110:53 amRNSTotal Voting Rights
17th Feb 20112:36 pmRNSDirector/PDMR Shareholding
9th Feb 201110:21 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.